跳至主要内容
临床试验/NCT04262492
NCT04262492招募中不适用

OBServaToire INternational Des Patients AnTiphospholipidEs traités Par Anticoagulants Oraux Directs

Stéphane Zuily2 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2020年10月21日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
500
试验地点
2
主要终点
Rate of Recurrent Thrombosis

研究概览

简要总结

This registry, currently being established will ensure consistency of data collection and provide safety information in non high-risk APS patients currently on DOACs.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patient receiving a comprehensive information about the study, and not opposed to participate
  • Age ≥ 18 yo
  • Classification of definite APS according to revised Sapporo-Sydney criteria
  • Direct oral anticoagulant treatment prescribed during at least 6 months or with the possibility of follow-up of at least 6 months

排除标准

  • Incomplete revised Sapporo-Sydney criteria
  • No data regarding the recurrent thrombosis
  • Pregnant woman
  • Age < 18 yo

结局指标

主要结局

Rate of Recurrent Thrombosis

时间窗: 6 months

Rate of Recurrent Thrombosis either arterial, venous or microvascular confirmed by a relevant exam

次要结局

  • Rate of Bleeding(6 months)
  • Adherence to treatment(6 months)
  • Rate of Non-Criteria Manifestations(6 months)

研究者

发起方
Stéphane Zuily
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Stéphane Zuily

Professor

Central Hospital, Nancy, France

研究点 (2)

Loading locations...

相似试验